Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
    • IPOs
  • InderesTV
  • Forum
  • Discovery
  • Om os
    • Fulgte selskaber
    • Team

BiBBInstruments

0,40 SEK

-4,53 %

Mindre end 1K følgere

BIBB

Spotlight Stock Market

Medical Equipment & Services

Health Care

Oversigt
Finansielt overblik og estimater
Ejerskab
Dividend
Investorkonsensus
Sammenligne
-4,53 %
-69,92 %
-83,24 %
-83,24 %
-85,26 %
-78,65 %
-84,06 %
-92,09 %
-91,83 %

BiBBInstruments operates in the medical technology sector. The company develops biopsy instruments based on its own technology platform. The technology is mainly used in specialist healthcare and surgical departments in the treatment of various forms of cancer. The products are sold as disposable instruments with a developed drilling function and are used at the diagnostic stage. The company was founded in 2013 and is headquartered in Lund.

Læs mere
Markedsværdi
81,48 mio. SEK
Aktieomsætning
19,87 t SEK
Omsætning
400 t
EBIT %
-3.667,5 %
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin

Omsætning t

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender
22.5
2026

Delårsrapport Q1'26

12.6
2026

Generalforsamling '26

21.8
2026

Delårsrapport Q2'26

Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Selskabsmeddelelsei går

BibbInstruments AB: BiBBInstruments receives additional subscription intentions in the ongoing rights issue

BiBBInstruments
Selskabsmeddelelse25.3.2026, 20.54

BibbInstruments AB: Correction: BiBBInstruments AB (publ) publishes updated information document in connection with rights issue - incorrect ISIN code for the share

BiBBInstruments
Selskabsmeddelelse24.3.2026, 16.34

BibbInstruments AB: BiBBInstruments AB (publ) publishes information document in connection with rights issue

BiBBInstruments

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto
Følgere og notifikationer om fulgte virksomheder
Analytikerkommentarer og anbefalinger
Værktøj til at sammenligne aktier og andre populære værktøjer
Opret konto
Selskabsmeddelelse19.3.2026, 13.32

BibbInstruments AB: BiBBInstruments resolves on the previously announced rights issue of approximately SEK 60.3 million

BiBBInstruments
Selskabsmeddelelse13.3.2026, 15.09

BibbInstruments AB: Communiqué from the Extraordinary General Meeting in BiBBInstruments AB held on 13 March 2026

BiBBInstruments
Selskabsmeddelelse10.2.2026, 15.45

BibbInstruments AB: Notice of Extraordinary General Meeting of BiBBInstruments AB (publ)

BiBBInstruments
Selskabsmeddelelse9.2.2026, 17.33

BibbInstruments AB: BiBBInstruments Announces the Board of Directors' Intention to Resolve on a Rights Issue of Approximately SEK 60 Million

BiBBInstruments
Pressemeddelelse19.12.2025, 09.39

BioStock: BiBBInstruments accelerates in the US – Q4 sales surge

BiBBInstruments
Selskabsmeddelelse17.12.2025, 10.16

BibbInstruments AB: BiBBInstruments receives additional orders for EndoDrill[®] GI from the U.S.

BiBBInstruments
Pressemeddelelse4.12.2025, 13.19

BioStock: BiBBInstruments validates clinical need during US tour

BiBBInstruments
Pressemeddelelse3.12.2025, 09.29

BibbInstruments AB: U.S. Tour Fall 2025 - BiBB Strengthens Its Presence in the American Market

BiBBInstruments
Pressemeddelelse10.11.2025, 06.48

BioStock: BiBBInstruments off the starting blocks for its U.S. launch

BiBBInstruments
Selskabsmeddelelse9.9.2025, 07.45

BibbInstruments AB: Initial Results from Mayo Clinic Indicate Potential of EndoDrill GI in Tissue Culture-Based Pancreatic Cancer Research

BiBBInstruments
Pressemeddelelse4.9.2025, 06.56

BibbInstruments AB: BiBB Engages EUS Pioneer Professor Peter Vilmann as Scientific Advisor

BiBBInstruments
Pressemeddelelse25.8.2025, 05.26

BioStock: BioStock: BiBBInstruments’ CEO looks forward to the upcoming launch

BiBBInstruments
Pressemeddelelse13.8.2025, 08.52

BioStock: BiBBInstruments’ CEO comments on the results of a clinical case series for EndoDrill GI in the U.S.

BiBBInstruments
Selskabsmeddelelse11.8.2025, 07.27

BibbInstruments AB: Henry Ford St. John Hospital Reports First U.S. Liver Biopsy Cases with EndoDrill GI

BiBBInstruments
Selskabsmeddelelse24.6.2025, 07.41

BibbInstruments AB: Decision to Grant Third EndoDrill[®] Patent in Japan

BiBBInstruments
Pressemeddelelse23.6.2025, 07.45

BioStock: BioStock: BiBBInstruments secures exclusive distribution agreement in the U.S.

BiBBInstruments
Selskabsmeddelelse18.6.2025, 12.04

BibbInstruments AB: BiBBInstruments announces date for conversion of exercised warrants of series TO 1 into shares

BiBBInstruments
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.